Saturday, 26 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Drug
Grand Pharma’s First-in-Class RDC ITM-11 Accepted for IND Review
January 16, 2025
Company
Deals
Jacobio Pharma Partners with WestChina-Frontier for Preclinical Safety Studies
January 16, 2025
Company
Drug
Mabwell’s IL-11 Monoclonal Antibody 9MW3811 Approved for Australian Clinical Trial
January 16, 2025
Company
Drug
AstraZeneca’s Calquence Administered in Hainan Ahead of Official Approval
January 16, 2025
Company
Deals
CARsgen Therapeutics Partners with Jinshan Hospital for CAR-T Research
January 16, 2025
Company
Deals
Sansure Biotech Partners with Shanghai Tenth People’s Hospital for Genomics Center
January 16, 2025
Company
Deals
Zhongchao and Johnson & Johnson Renew Partnership for Digital Health Services
January 17, 2025
Company
Drug
CStone’s Sugemalimab Accepted for EU Marketing Authorization by EMA
January 16, 2025
Company
Deals
Danatlas Raises Pre-Series A Funding for Synthetic Lethality Drug Development
January 16, 2025
Company
Drug
CDE Signals Priority Review for Sanofi’s Dupixent and Other Drugs
January 16, 2025
Company
Drug
InnoCare and Keymed Announce First Dosing of ICP-B05 Clinical Study
January 16, 2025
Company
Drug
Luye Pharma’s Paliperidone Palmitate Approved for European Clinical Trials
January 16, 2025
1
2
…
1,028
1,029
1,030
1,031
1,032
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?